Present value of tumor markers in the clinic.
D000951:Antigens, Neoplasm / Q000032:analysis; D002272:Carcinoembryonic Antigen / Q000032:analysis; D000013:Congenital Abnormalities / Q000175:diagnosis; D005700:Galactosyltransferases / Q000097:blood; D006801:Humans; D009369:Neoplasms / Q000032:analysis* / Q000175:diagnosis; D010455:Peptides / Q000032:analysis; D012260:Ribonucleases / Q000097:blood; D012799:Sialyltransferases / Q000097:blood; D019396:Tissue Polypeptide Antigen; D000509:alpha-Fetoproteins / Q000032:analysis; D000094802:beta-D-Galactoside alpha 2-6-Sialyltransferase
D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen; D010455:Peptides; C033814:Tennessee antigen, human; D019396:Tissue Polypeptide Antigen; D000509:alpha-Fetoproteins; D005700:Galactosyltransferases; D012799:Sialyltransferases; D012260:Ribonucleases; D000094802:beta-D-Galactoside alpha 2-6-Sialyltransferase